Which are the causes of Dupuytrens Contracture?

TL;DR: Dupuytren’s contracture is a fibroproliferative disorder of the hand, meaning the connective tissue in the palm abnormally thickens and shortens, causing fingers to curl inward. While the exact cause remains unknown, it is widely considered a multifactorial condition driven by a combination of genetic predisposition, environmental triggers, and underlying metabolic influences.

What exactly causes Dupuytren’s contracture?

In Dupuytren’s contracture, the palmar fascia—a layer of tissue lying just under the skin of your palm—undergoes a transformation. Normally, this tissue is thin and flexible, but in affected individuals, it begins to produce excess collagen, forming firm nodules and eventually tough, cord-like bands. These cords act like a tightened drawstring on a garment, pulling the finger toward the palm. Researchers believe this is triggered by an abnormal wound-healing response where the body continues to produce tissue long after it is needed, though the precise biological "switch" that initiates this process is still a subject of intense scientific study.

Is there a genetic component to Dupuytren’s contracture?

Yes, genetics play a significant role in the development of Dupuytren’s contracture. It is often referred to as "Viking disease" due to its higher prevalence in populations of Northern European descent. Studies suggest that up to 70% of patients have a positive family history, indicating a strong hereditary link. Researchers have identified several susceptibility loci—specific areas on our chromosomes—associated with the condition, including variations in the Wnt signaling pathway, which controls how cells grow and communicate. While it is not a simple "single-gene" mutation, inheriting certain genetic markers significantly increases your likelihood of developing the condition.

What are the primary risk factors and environmental triggers?

While genetics provide the blueprint, environmental and lifestyle factors often act as catalysts for Dupuytren’s contracture. It is important to distinguish between a "cause" (the root mechanism) and a "risk factor" (a condition that makes the disease more likely to manifest). Common risk factors include:

• Age and Gender: It is most common in individuals over the age of 50, and men are significantly more likely to develop Dupuytren’s contracture than women.


• Metabolic Health: There is a well-documented association between the disease and diabetes, as well as alcohol consumption and tobacco use.


• Repetitive Trauma: While controversial, some research suggests that chronic, repetitive vibration or manual labor may trigger the condition in genetically susceptible individuals.


• Associated Conditions: Individuals with Dupuytren’s contracture are sometimes prone to other fibrotic conditions, such as Ledderhose disease (foot nodules) or Peyronie’s disease.

How is current research improving our understanding?

Current clinical research is shifting focus toward the cellular environment of the hand. Scientists are currently investigating myofibroblasts—the specific cells responsible for the contraction—to see if they can be "reprogrammed" to stop producing excess collagen. With 167 members of the DiseaseMaps.org community currently sharing their experiences with Dupuytren’s contracture, we are gathering valuable real-world data that helps researchers understand the progression of symptoms, including the often-overlooked pain in the hand and shoulder regions. Understanding these systemic connections is a major priority for the next generation of therapies.

Next steps

• Consult with a hand surgeon or a rheumatologist to evaluate the stage of your Dupuytren’s contracture.


• Keep a symptom diary to track the progression of your nodules and the restriction of movement in your fingers.


• Join the DiseaseMaps.org community to connect with others and share experiences regarding different treatments like radiation or injections.


• Discuss with your primary care physician whether your metabolic health markers, such as blood glucose, are optimized.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Dupuytren's contracture profile.


• Orphanet: Rare disease database on connective tissue disorders.


• OMIM (Online Mendelian Inheritance in Man): Entry #126900 regarding genetic susceptibility to Dupuytren's.


• The Dupuytren Research Group: Patient-centered clinical trial and research updates.